Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Details)

v2.4.0.8
STOCK-BASED COMPENSATION (Details) (USD $)
3 Months Ended 6 Months Ended 0 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Feb. 21, 2014
Stock Options [Member]
Jun. 30, 2014
Stock Options [Member]
Jun. 30, 2014
Stock Options [Member]
Jun. 30, 2014
Director [Member]
Stock Options [Member]
Jun. 30, 2013
Director [Member]
Stock Options [Member]
Jun. 30, 2014
Director [Member]
Stock Options [Member]
Jun. 30, 2013
Director [Member]
Stock Options [Member]
Jun. 30, 2014
Mr. Hatem El Khalidi [Member]
Stock Options [Member]
Jun. 30, 2014
Mr. Hatem El Khalidi [Member]
Stock Options [Member]
Jun. 30, 2014
Officer and Key Employees [Member]
Stock Options [Member]
Jun. 30, 2013
Officer and Key Employees [Member]
Stock Options [Member]
Jun. 30, 2014
Officer and Key Employees [Member]
Stock Options [Member]
Jun. 30, 2013
Officer and Key Employees [Member]
Stock Options [Member]
Fair value of the warrants granted calculated using the Black-Scholes valuation model, Assumptions [Abstract]                                  
Expected volatility (in hundredths)             84.00%                    
Expected dividends                [1]                    
Expected term (in years)             6 years 3 months                    
Risk free interest rate (in hundredths)             1.95%                    
Stock Options and Warrants [Roll Forward]                                  
Outstanding at beginning of period (in shares)             1,326,360                    
Granted (in shares)         500,000   500,000                    
Vesting percentage (in hundredths)         25.00%                        
Exercised (in shares)             (31,820)                    
Expired (in shares)             0                    
Cancelled (in shares)             0                    
Forfeited (in shares)             (20,000)                    
Outstanding at end of period (in shares)           1,774,540 1,774,540                    
Exercisable, end of period (in shares)           662,068 662,068                    
Weighted Average Exercise Price Per Share [Roll Forward]                                  
Outstanding at beginning of period (in dollars per share)             $ 4.75                    
Granted (in dollars per share)             $ 12.26                    
Exercised (in dollars per share)             $ 2.86                    
Expired (in dollars per share)             $ 0                    
Cancelled (in dollars per share)             $ 0                    
Forfeited (in dollars per share)             $ 2.82                    
Outstanding at end of period (in dollars per share)           $ 6.92 $ 6.92                    
Exercisable, end of period (in dollars per share)           $ 4.53 $ 4.53                    
Weighted Average Remaining Contractual Life [Abstract]                                  
Outstanding, weighted average remaining contractual life             7 years 1 month 6 days                    
Exercisable, weighted average remaining contractual life             5 years 10 months 24 days                    
Options awarded, term (in years)         10 years                        
Vesting period         4 years   4 years               4 years 4 years 4 years
Compensation expense     973,000 548,000   277,000 400,000         24,000 49,000 150,000 119,000 300,000 238,000
Directors fees and expenses related to options to purchase shares               76,000 94,000 170,000 189,000            
Common Stock, issued (in shares) 100,000   100,000                            
Investor relations expense $ 21,000 $ 42,000 $ 54,000 $ 71,000                          
[1] None